Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
UCB |
---|---|
Information provided by: | UCB |
ClinicalTrials.gov Identifier: | NCT00160589 |
Two weeks study to evaluate the efficacy and safety of Levocetirizine and Desloratadine in patients suffering from Allergic Rhinitis (AR)
Condition | Intervention | Phase |
---|---|---|
Rhinitis, Allergic, Perennial |
Drug: Levocetirizine |
Phase IV |
Study Type: | Interventional |
Study Design: | Randomized, Double-Blind, Placebo Control, Parallel Assignment |
Official Title: | A Multicentre, Double-Blind, Parallel, Randomized, Placebo-Controlled Study : Evaluation of the Efficacy and Safety of Levocetirizine 5 mg and Desloratadine 5 mg Administered Orally as Capsules Once Daily, in the Morning, Over 2 Weeks in Patients Suffering From Allergic Rhinitis (AR) |
Estimated Enrollment: | 729 |
Study Start Date: | April 2005 |
Study Completion Date: | September 2005 |
Primary Completion Date: | September 2005 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | A00401, EudraCT2004-002823-42, LEADER |
Study First Received: | September 8, 2005 |
Last Updated: | March 6, 2008 |
ClinicalTrials.gov Identifier: | NCT00160589 |
Health Authority: | France: Afssaps - French Health Products Safety Agency; Germany: Federal Institute for Drugs and Medical Devices; Italy: Ministry of Health |
Allergic Rhinits, Symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), LEADER, Xyzal, Levocetirizine |
Pruritus Otorhinolaryngologic Diseases Rhinitis Cetirizine Desloratadine Histamine Hypersensitivity |
Rhinitis, Allergic, Perennial Respiratory Tract Diseases Respiratory Tract Infections Levocetirizine Hypersensitivity, Immediate Histamine phosphate Respiratory Hypersensitivity |
Neurotransmitter Agents Immune System Diseases Cholinergic Antagonists Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Histamine Agents Anti-Allergic Agents |
Cholinergic Agents Nose Diseases Pharmacologic Actions Histamine Antagonists Therapeutic Uses Histamine H1 Antagonists Histamine H1 Antagonists, Non-Sedating |